e-learning
resources
London 2016
Sunday, 04.09.2016
Pharmacological management of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of different inhalation methods on the airway clearance in moderate and severe AECOPD
Hongjing Lin (Changchun City, China), Hongjing Lin, Xin Zhong, Zeyu Qin, Xueli Zhang, Jiahui Ma
Source:
International Congress 2016 – Pharmacological management of COPD
Session:
Pharmacological management of COPD
Session type:
Poster Discussion
Number:
297
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Hongjing Lin (Changchun City, China), Hongjing Lin, Xin Zhong, Zeyu Qin, Xueli Zhang, Jiahui Ma. Effect of different inhalation methods on the airway clearance in moderate and severe AECOPD. Eur Respir J 2016; 48: Suppl. 60, 297
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Short-term effects of bronchial thermoplasty on pulmonary function in patients with severe asthma
Source: International Congress 2016 – Airway stenting and ablation
Year: 2016
Improved effects of formoterol-budesonide combination on residual eosinophilic inflammation in asthmatic peripheral airway
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013
Treating asthma means treating airway smooth muscle cells
Source: Eur Respir J 2008; 32: 265-274
Year: 2008
Atomization inhalation on the NO content in the airway of patients with bronchial asthma
Source: International Congress 2016 – The wide spectrum of respiratory nursing research and practice: across all ages and diseases
Year: 2016
Long-term effects of bronchial thermoplasty on airway smooth muscle and collagen deposition in severe asthma
Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives
Year: 2016
Simulation of airway calibre and inflammation interaction by a new model of airway epithelium
Source: International Congress 2015 – Respiratory muscles and airways function: from physiology to clinical implications
Year: 2015
Indirect comparison of bronchial thermoplasty (BT) versus omalizumab (OM) for severe uncontrolled asthma
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015
Bronchial thermoplasty in uncontrolled severe persistent asthma. Preliminary results
Source: International Congress 2016 – Airway stenting and ablation
Year: 2016
Computational modeling methods for simulating obstructive human lung diseases
Source: International Congress 2016 – The future of lung function is beginning now
Year: 2016
Improved effects of aerosol-type fluticasone propionate/formoterol combination on residual asthmatic inflammation in distal airways of patients with moderate asthma
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
Exaggerated airway narrowing is related to increased airway smooth muscle mass in bronchial segments from subjects with a history of asthma
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013
BioPhysical bronchodilator: A new class of respiratory drug
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
Effects of ciclesonide on the management of stable COPD with airway eosinophilia
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Airway inflammation and airway dynamics during deep inspiration in asthma and COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 831s
Year: 2006
More relaxation by deep inhalation of methacholine than exercise-pretoned airways of asthmatic children
Source: International Congress 2015 – Lung function: new findings and approaches
Year: 2015
Airway smooth muscle thickness in asthma is related to severity but not duration of asthma
Source: Eur Respir J 2009; 34: 1040-1045
Year: 2009
Distribution of increased airway smooth muscle thickness and airway inflammation in asthma
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013
Pharmacologic bronchodilation response to salbutamol in COPD patients
Source: International Congress 2014 – Predictors
Year: 2014
Effect of inhaled vilanterol trifenatate/fluticasone furoate on breathing pattern, dyspnea and respiratory muscle function in severe COPD
Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases
Year: 2014
Involvement of airway eosinophilia and airway hyperresponsiveness in management and therapy for COPD>
Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept